ARA 290, a Peptide Derived from the Tertiary Structure of Erythropoietin, Produces Long-Term Relief of Neuropathic Pain Coupled with Suppression of the Spinal Microglia Response
Maarten Swartjes(Leiden University Medical Center), Albert Dahan(Centre for Human Drug Research), Monique van Velzen(Leiden University Medical Center), Marieke Niesters(Leiden University Medical Center), Ann Dunne(Araim Pharmaceuticals (United States)), Anthony Cerami(Araim Pharmaceuticals (United States)), Leon Aarts, Michael Brines(Northwell Health)
Cited by 36
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Decontamination of the Digestive Tract and Oropharynx in ICU Patients
|New England Journal of Medicine|2008|823